Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen Announces Partnership with Applied Maths

Published: Tuesday, June 04, 2013
Last Updated: Tuesday, June 04, 2013
Bookmark and Share
Strategic collaboration to provide bioinformatics analysis software for whole genome mapping.

OpGen, Inc., has announced the company has entered into a strategic collaboration with Applied Maths NV to provide advanced software tools for microbial genomics and molecular strain typing.

Under the agreement, Applied Maths has incorporated a Whole Genome Mapping module into the company’s new BioNumerics 7 software suite, providing customers with seamless access to a new set of analytical tools for molecular typing and comparative genomics of microbial pathogens.

“We are pleased to be working with Applied Maths to enable our public health, biodefense and microbial research customers access to Applied Maths’ BioNumerics analysis suite,” said Douglas White, chief executive officer of OpGen, Inc.

White continued, “The Applied Maths software and database analysis suite will provide a flexible, integrated solution that will enable broader adoption of Whole Genome Mapping.”

“The efficient management of food-borne pathogen outbreaks through enhanced approaches for epidemiological surveillance requires the rapid detection of potential outbreaks and improved molecular typing solutions,” said Koen Janssens, chief executive officer of Applied Maths.

Janssens continued, “We are pleased to be able to offer our customers access to OpGen’s Whole Genome Mapping technology in the recently released version of our BioNumerics software suite, enabling a one-stop application to distinguish between bacterial strains when analyzing disease outbreaks. This integrated solution will enable researchers to strain type and identify responsible pathogens in a timelier manner, which is crucial to limit outbreaks in time and scope and appropriately treat patients with food borne illnesses.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen and Hitachi Enter into an Agreement
The companies to develop offering that combines Whole Genome Mapping™ with cloud-based informatics and data management platforms.
Thursday, October 17, 2013
OpGen Assists 100K Genome Project
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.
Thursday, December 20, 2012
OpGen Announces Formation of Public Health Consortium
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.
Friday, May 18, 2012
OpGen Announces Strategic Collaboration with IQT
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.
Tuesday, May 01, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
OpGen Receives Frost & Sullivan New Product Innovation Award
OpGen, Inc. announces the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation for their Whole Genome Mapping System.
Wednesday, August 24, 2011
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!